Balyasny Asset Management »

Elevation Oncology shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.7M 2.5M 2.70
2024-03-31 $16M 3.1M 5.13

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Elevation Oncology

Logos Global Management
Farallon Capital Management
Tang Capital Management
Frazier Life Sciences Management
Aisling Capital Management
BlackRock
Balyasny Asset Management
Braidwell
venBio Partners
Hudson Bay Capital Management
BVF
Vanguard Group
Darwin Global Management
Palo Alto Investors
Point72 Asset Management

View all funds holding Elevation Oncology